Statins in risk-reduction and treatment of cancer

doi:10.5306/wjco.v11.i8.573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9515)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

574

WORD

282

HTML

6301

Tables (1-2)

304

Sum=7461

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

757

Download

1297

Sum=2054

Aug 24, 2020 (publication date) through Nov 16, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Aug 24, 2020; 11(8): 573-588
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.573

Statins in risk-reduction and treatment of cancer

Cristina I Barbalata, Lucia R Tefas, Marcela Achim, Ioan Tomuta, Alina S Porfire

Cristina I Barbalata, Lucia R Tefas, Marcela Achim, Ioan Tomuta, Alina S Porfire, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu-Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca 400012, Romania

Author contributions: Barbalata CI wrote the manuscript with support from Tefas LR, Achim M and Porfire AS; Porfire AS and Barbalata CI conceived the idea and organized the manuscript; Porfire AS and Tomuta I supervised the project and approved the final manuscript.

Conflict-of-interest statement: The authors declare no conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Corresponding author: Alina S Porfire, PhD, Associate Professor, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu- Hatieganu” University of Medicine and Pharmacy, 41 Victor Babes, Cluj-Napoca 400012, Romania. aporfire@umfcluj.ro

Received: February 28, 2020
Peer-review started: February 28, 2020
First decision: April 29, 2020
Revised: May 18, 2020
Accepted: June 10, 2020
Article in press: June 10, 2020
Published online: August 24, 2020
Processing time: 174 Days and 4.9 Hours

Core Tip

Core tip: In the last few years, statins have been increasingly studied for their anticancer properties. This review presents the application of statins in cancer management by outlining the latest in vitro and in vivo studies. The results represent the foundation of the latest clinical trials in order to search for new treatment directions in cancer therapy.